Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Natalie Raffoul"'
Autor:
Art Brion, Natalie Raffoul
Publikováno v:
Technology Innovation Management Review, Iss December 2011: Intellectual Property Rights, Pp 29-33 (2011)
Many innovative small and medium enterprises (SMEs) do not seek patent protection for their innovations, either because they are skeptical about the perceived benefits or wary of the perceived costs. However, by failing to protect their intellectual
Externí odkaz:
https://doaj.org/article/3d77615456b142308a95a6958d6dbfcf
Autor:
Natalie C. Ward, Gerald F. Watts, Warrick Bishop, David Colquhoun, Christian Hamilton-Craig, David L. Hare, Nadarajah Kangaharan, Karam M. Kostner, Leonard Kritharides, Richard O’Brien, Trevor A. Mori, Paul J. Nestel, Stephen J. Nicholls, Peter J. Psaltis, Natalie Raffoul, Harvey D. White, David R. Sullivan
Publikováno v:
Heart, Lung and Circulation. 32:287-296
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0493d89f230871a46c17bac3c9f6dcbf
https://doi.org/10.1016/j.hlc.2022.11.015
https://doi.org/10.1016/j.hlc.2022.11.015
Publikováno v:
Medical Journal of Australia. 218:103-105
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76ccbf85bfc497e5c3d1d2bb5b6cb5d0
https://doi.org/10.5694/mja2.51821
https://doi.org/10.5694/mja2.51821
Publikováno v:
Australian journal of general practice. 50(4)
Background and objectives Approximately 65% of cardiovascular disease (CVD)-related deaths in Australia occur in people with diabetes or pre-diabetes. The aim of this study was to investigate general practice management of risk factors among patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87a89b8355226a1363503b2052152c2b
https://pubmed.ncbi.nlm.nih.gov/33786549
https://pubmed.ncbi.nlm.nih.gov/33786549
Autor:
Carissa Bonner, Natalie Raffoul, Tanya Battaglia, Julie Anne Mitchell, Carys Batcup, Bill Stavreski
BACKGROUND Heart age calculators are used worldwide to engage the public in cardiovascular disease (CVD) prevention. Experimental studies with small samples have found mixed effects of these tools, and previous reports of population samples that used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78f6f6ee387eb7ab554ff6204d90b6c5
https://doi.org/10.2196/preprints.19028
https://doi.org/10.2196/preprints.19028
Publikováno v:
Australian journal of primary health. 26(6)
Dyslipidaemia is a major risk factor for cardiovascular disease (CVD) and is routinely managed by GPs. Lipid-modifying medicines, commonly statins, are used to treat dyslipidaemia and prevent CVD in high-risk individuals. A national education program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c532e4267bb1f546fff70c56798e083
https://pubmed.ncbi.nlm.nih.gov/33004108
https://pubmed.ncbi.nlm.nih.gov/33004108
Publikováno v:
Journal of the American College of Cardiology. 75:3617
An ability to explain risk in order to motivate behavior change is a perennial public health challenge. In February 2019, the Australian Heart Foundation launched an online Heart Age Calculator (HAC) based on the Framingham multivariate risk equation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8518df7c08ed8d8c368562ecaeed7594
https://doi.org/10.1016/s0735-1097(20)34244-3
https://doi.org/10.1016/s0735-1097(20)34244-3